Skip to main content
SpringerLink
Log in

Neuropharmacology of Genus Hypericum: Hypericin and Hyperforin

  • Chapter
  • First Online:
Pharmacotherapeutic Potential of Natural Products in Neurological Disorders

  • 700 Accesses

Abstract

H. perforatum is known by various names including Amber touch-and-heal, balm-of-warrior’s wound, devil’s scourge, god’s wonder plant, Klamath weed, goatweed, perforate St John’s wort, rosin rose, touch and heal and witcher’s herb. However, St John’s wort is widely and popularly used common name of H. perforatum (Upton 1997). The word St John’s wort is given to plant because it was harvested on the occasion of St John’s day, which falls on 24th of the June (Gunther 1968).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bach-Rojecky L, Kalodjera Z, Samarzija I. The antidepressant activity of Hypericum perforatum L. measured by two experimental methods on mice. Acta Pharma. 2004;54:157–62.

    CAS  Google Scholar 

  • Baureithel KH, Berger Buter K, Engesser A, Bukard W, Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm Act Helvetiae. 1997;72:153–7.

    Article  CAS  Google Scholar 

  • Beijamini V, Andreatini R. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Pharmacol Res. 2003;48:199–207.

    Article  CAS  PubMed  Google Scholar 

  • Berghoefer R, Hoelzl J. Bioflavonoids in Hypericum perforatum. Part 1. Isolation of 13, II8- biapigenin. Planta Med. 1987;53:216–7.

    Article  CAS  Google Scholar 

  • Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatry Neurol. 1994;7:57–9.

    Article  Google Scholar 

  • Bombardelli E, Morazzoni P. Hypericum perforatum. Fitoterpia. 1995;66:43–68.

    CAS  Google Scholar 

  • Bombardelli E, Morazzoni P, Riva A. IDN 5491 (Hyperforin trimethoxybenzoate): A new antidepressive drug. Eur Neuropsychopharmacol 2002;12:240.

    Article  Google Scholar 

  • Brenn A, Grube M, Jedlitschky G, Fischer A, Strohmeier B, Eiden M, Keller M, Groschup MH, Vogelgesang S. St. John’s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer’s disease mouse model-role of P-glycoprotein. Brain Pathol. 2014;24:18–24.

    Article  PubMed  Google Scholar 

  • Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Paris: Lavoisier Publishing; 1995.

    Google Scholar 

  • Butterweck V. Mechanism of action of St John’s Wort in depression. CNS Drugs. 2003;17:539–62.

    Article  CAS  PubMed  Google Scholar 

  • Butterweck V, Petereit F, Winterhoff H. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med. 1998;64:291–4.

    Article  CAS  PubMed  Google Scholar 

  • Butterweck V, Jurgenliemk G, Nahrstedt A, Winthehoff H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Thieme: Fachzeitschriften: Planta Medica 2000;66:3–6.

    Article  CAS  PubMed  Google Scholar 

  • Calapai G, Crupi A, Firenzuoli F, Inferrera G, Ciliberto G, Parisi A, De Sarro G, Caputi AP. Interleukin-6 involvement in antidepressant action of Hypericum perforatum. Pharmacopsychiatry. 2001a;34:8–10.

    Article  Google Scholar 

  • Calapai G, Crupi A, Firenzuoli F, Inferrera G, Squadrito F, Parisi A, De Sarro G, Caputi A. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum. Pharmacopsychiatry. 2001b;34:45–9.

    Article  CAS  PubMed  Google Scholar 

  • Can OD, Ozkay UD. Effects of Hypericum montbretti extract on the central nervous system and involvement of GABA (A)/Benzodiazepine receptors in its pharmacological activity. Phytother Res. 2012;26:1695–700.

    Article  CAS  PubMed  Google Scholar 

  • Can OD, Ismail IB, Oztürk Y, Oztürk N, Potoğlu-Erkara I, Sagratini G, Ricciutelli M, Vittori S, Maggi F. New antidepressant drug candidate: Hypericum montbretti extract. Nat Prod Res. 2011a;25:1469–72.

    Article  CAS  PubMed  Google Scholar 

  • Can OD, Oztürk Y, Ozkay UD. Effects of insulin and St. John’s Wort treatments on anxiety, locomotory activity, depression, and active learning parameters of streptozotocin-diabetic rats. Planta Med. 2011b;77:1970–6.

    Article  CAS  PubMed  Google Scholar 

  • Centurião FB, Braga A, Machado FR, Tagliari B, Müller LG, Kolling J, Gv P, Wyse AT, Rates SM. Study of antidepressant-like activity of an enriched phloroglucinol fraction obtained from Hypericum caprifoliatum. Pharm Biol. 2014;52:105–10.

    Article  CAS  PubMed  Google Scholar 

  • Chang Y, Wang SJ. Hypericin, the active component of St. John’s wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway. Eur J Pharmacol. 2010;634:53–61.

    Article  CAS  PubMed  Google Scholar 

  • Davidson JRT, Gadde KM, Fairbank JA, et al. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287(14):1807.

    Article  Google Scholar 

  • Eckert GP, Muller WE. Effects of hyperforin on the fluidity of brain membranes. Pharmacopsychiatry. 2001;34:22–5.

    Article  Google Scholar 

  • Erdelmeier CAJ. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsychiatry. 1998;31:2–6.

    Article  CAS  PubMed  Google Scholar 

  • Findling RL, McNamara NK, O’Riordan MA, Reed MD, Demeter CA, Branicky LA, Blumer JL. An open-label pilot study of St. John’s wort in juvenile depression. J Am Acad Child Adolesc Psychiatry. 2003;42:908–14.

    Article  PubMed  Google Scholar 

  • Flausino OA Jr, Zangrossi H Jr, Salgado JV, Viana MB. Effects of acute and chronic treatment with Hypericum perforatum L. (LI 160) on different anxiety-related responses in rats. Pharmacol Biochem Behav. 2002;71:251–7.

    Article  CAS  PubMed  Google Scholar 

  • Gastpar M, Singer A, Zeller K. 2005. Efficacy and tolerability of Hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry. 2005;38:78–86.

    Article  CAS  PubMed  Google Scholar 

  • Gastpar M, Singer A, Zeller K. 2006. Comparative efficacy and safety of a once-daily dosage of Hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry 2006;39:66–75.

    Article  CAS  PubMed  Google Scholar 

  • Gómez del Rio MA, Sánchez-Reus MI, Iglesias I, Pozo MA, García-Arencibia M, Fernández-Ruiz J, García-García L, Delgado M, Benedí J. Neuroprotective properties of standardized extracts of Hypericum perforatum on rotenone model of Parkinson’s disease. CNS Neurol Disord Drug Targets. 2013;12:665–79.

    Article  PubMed  Google Scholar 

  • Grundmann O, Kelber O, Butterweck V. Effects of St. John’s wort extract and single constituents on stress-induced hyperthermia in mice. Planta Med. 2006;72:1366–71.

    Article  CAS  PubMed  Google Scholar 

  • Gunther RT. The Greek herbal of dioscorides. New York: Hafner Pub Co. 1968.

    Google Scholar 

  • Hansgen KD, Vesper J, Ploch M. Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extracts LI 160. J Geriatr Psychiatry Neurol. 1994;7:15–8.

    Article  Google Scholar 

  • Harrer G, Hubner WD, Podzuweit H. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study. J Geriatr Psychiatry Neurol. 1994;7:24–8.

    Article  Google Scholar 

  • Hoffmann J, Kühl ED. Therapy of depressive states with hypericin. ZFA (Stuttgart) 1979;55:776–782.

    Google Scholar 

  • Hubner WD, Lande S, Podzuweit H. Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatry Neurol. 1994;1:12–4.

    Article  Google Scholar 

  • Husain GM, Chatterjee SS, Singh PN, Kumar V. Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model. Acta Pol Pharm. 2011;68:913–8.

    PubMed  Google Scholar 

  • Jensen AG, Hansen SH, Nielsen EO. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. Life Sci. 2001;68:1593–605.

    Article  CAS  PubMed  Google Scholar 

  • Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A. Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers. J Geriatr Psychiatry Neurol. 1994;7:44–6.

    Article  Google Scholar 

  • Kaehler ST, Sinner C, Chatterjee SS, Philippu A. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett. 1999;262:199–202.

    Article  CAS  PubMed  Google Scholar 

  • Kasper S. Treatment of seasonal affective disorder (SAD) with Hypericum extract. Pharmacopsychiatry. 1997;30:89–93.

    Article  PubMed  Google Scholar 

  • Kiasalari Z, Baluchnejadmojarad T, Roghani M. Hypericum perforatum Hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in Intrastriatal 6-Hydroxydopamine rat model of Parkinson’s disease. Cell Mol Neurobiol. 2016;36:521–30.

    Article  CAS  PubMed  Google Scholar 

  • Kitanov G. Determination of the absolute configuration of catechins isolated from Hypericum perforatum. Farmatsiya (Sofia) 1983;33:19–22.

    Google Scholar 

  • Koget TA. Determination of the amount of quercitrin in Hypericum perforatum. Khim Prir Soedin. 1972;(2):242–3.

    Article  Google Scholar 

  • Kumar A, Singh A. Protective effect of St. John’s wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Planta Med. 2007;73:1358–64.

    Article  CAS  PubMed  Google Scholar 

  • Kumar V, Singh PN, Jaiswal AK, Bhattacharya SK. Antidepressant activity of Indian Hypericum perforatum Linn in rodents. Indian J Exp Biol. 1999;37:1171–6.

    PubMed  CAS  Google Scholar 

  • Kumar V, Jaiswal AK, Singh PN, Bhattacharya SK. Anxiolytic activity of Indian Hypericum perforatum Linn: an experimental study. Indian J Exp Biol. 2000;38:36–41.

    PubMed  CAS  Google Scholar 

  • Kumar V, Singh PN, Bhattacharya SK. Anti-stress activity of Indian Hypericum perforatum L. Indian J Exp Biol. 2001;39:344–9.

    PubMed  CAS  Google Scholar 

  • Laakmann G, Schule C, Baghai T, Kieser M. St. John’s wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 1998;31:54–9.

    Article  CAS  PubMed  Google Scholar 

  • Leung AY, Foster S. Encyclopedia of common natural ingredients used in food, drugs and cosmetics. 2nd. ed. New York: Wiley; 1996.

    Google Scholar 

  • Liu J, Fang Y, Wei Z, Yang X, Zeng L. Synergic antidepressive effect of quercetin and Hypericum perforatum extract in mice. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013;42:615–9.

    PubMed  CAS  Google Scholar 

  • Maisenbacher P, Kovar KA. Adhyperforin - a homologue of hyperforin from Hypericum perforatum. Planta Med. 1992;58:291–3.

    Article  CAS  PubMed  Google Scholar 

  • Mathis C, Ourisson G. Etude Chimio-taxonomique du genre Hypericum. Phytochemistry. 1964;3:379.

    Article  CAS  Google Scholar 

  • Mennini T, Gobbi M. The antidepressant mechanism of Hypericum perforatum. Life Sci. 2004;75:1021–7.

    Article  CAS  PubMed  Google Scholar 

  • Mukherjee KP, Suresh B, Verpoorte R. {CNS} active potentials of some Hypericum species of India. Phytomedicine. 2001;8:331–7.

    Article  CAS  PubMed  Google Scholar 

  • Müldner H, Zöller M. Antidepressive effect of a Hypericum extract standardized to an active hypericine complex. Biochemical and clinical studies. Arzneimittelforschung. 1984;34:918–20.

    PubMed  Google Scholar 

  • Muller WE, Rolli M, Schafer C, Hafner U. Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry. 1997;30:102–7.

    Article  CAS  PubMed  Google Scholar 

  • Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. 1998;1:16–21.

    Article  Google Scholar 

  • Muller WE, Singer A, Wonnemann M. Hyperforin-antidepressant activity by a novel mechanism of action. Pharmacopsychiatry. 2001;34:98–102.

    Article  Google Scholar 

  • Muruganandam AV, Ghosal S, Battacharya SK. The role of xanthones in the antidepressant activity of Hypericum perforatum involving dopaminergic and serotonergic systems. Biogenic Amines. 2000;15:553–67.

    Google Scholar 

  • Muruganandam AV, Bhattacharya SK, Ghosal S. Antidepressant activity of hyperforin conjugates of the St. John’s wort, Hypericum perforatum Linn.: an experimental study. Indian J Exp Biol. 2001;39:1302–4.

    PubMed  CAS  Google Scholar 

  • Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res. 1999;816:358–63.

    Article  CAS  PubMed  Google Scholar 

  • Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health care professionals. London: The Pharmaceutical Press; 1996.

    Google Scholar 

  • Niederhofer H. St. John’s wort may diminish methylphenidate’s efficacy in treating patients suffering from attention deficit hyperactivity disorder. Med Hypotheses. 2007;68:1189.

    Article  CAS  PubMed  Google Scholar 

  • Niederhofer H. St John’s wort treating patients with autistic disorder. Phytother Res. 2009;23:1521–3.

    Article  PubMed  Google Scholar 

  • Niederhofer H. St. John’s wort may improve some symptoms of attention-deficit hyperactivity disorder. Nat Prod Res. 2010;24:203–5.

    Article  CAS  PubMed  Google Scholar 

  • Nöldner M, Schötz K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med. 2002;68:577–80.

    Article  PubMed  Google Scholar 

  • Okpanyi SN, Weischer ML. Animal experiments on the psychotropic action of a Hypericum extract. Arzneimittelforschung. 1987;37:10–3.

    PubMed  CAS  Google Scholar 

  • Öztürk Y, Aydin S, Beis R, Baser KHC, Berberoglu H. Effects of Hypericum calycinum L. extract on the central nervous system in mice. Phytother Res. 1996;10:700–2.

    Article  Google Scholar 

  • Perovic S, Muller WE. Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung. 1995;45:1145–8.

    PubMed  CAS  Google Scholar 

  • Pongiya UD, Kandanath BM, Rao YR, RafiqKhan M. Protective effect of Hypericum hookerianum in reversing haloperidol induced schizophrenia-like behaviors in Swiss albino mice. Asian J Biomed Pharm Sci. 2014;4(33):14–23.

    Article  Google Scholar 

  • Rasmussen PS. John’s wort-a review of its use in depression. Australian J Med Herbalism. 1998;10:8–13.

    Google Scholar 

  • Sánchez-Mateo CC, Bonkanka CX, Prado B, Rabanal RM. Antidepressant activity of some Hypericum reflexum L. fil. Extracts in the forced swimming test in mice. J Ethnopharmacol. 2007;112:115–21.

    Article  PubMed  Google Scholar 

  • Sánchez-Mateo CC, Bonkanka CX, Rabanal RM. Hypericum grandifolium Choisy: a species native to Macaronesian Region with antidepressant effect. J Ethnopharmacol. 2009;121:297–303.

    Article  PubMed  Google Scholar 

  • Scheggi S, Marandino A, Del Monte D, De Martino L, Pelliccia T, Del Rosario Fusco M, Petenatti EM, Gambarana C, De Feo V. The protective effect of Hypericum connatum on stress-induced escape deficit in rat is related to its flavonoid content. Pharm Biol. 2016;54:1782–92.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt U, Sommer H. St. John’s wort extract in the ambulatory therapy of depression. Attention and reaction ability are preserved. Fortschr Med. 1993;111:339–42.

    PubMed  CAS  Google Scholar 

  • Schrader E. Equivalence of St John’s wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Clin Psychopharmacol. 2000;15:61–8.

    Article  CAS  Google Scholar 

  • Seifritz E, Hatzinger M, Holsboer-Trachsler E. Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis. Int J Psychiatry Clin Pract. 2016;20:126–32.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shanmugam M, Shanmugasundaram KK. Biochemical and phytochemical characterization of Hypericum mysorense - an antidepressant unexploited medicinal plant of Nilgiris biosphere. Ancient Sci Life. 2009;29:29–32.

    Google Scholar 

  • Simmen U, Bobirnac I, Ullmer C, Lubbert H, Berger Buter K, Schaffner W, Schoeffter P. Antagonist effect of pseudohypericin at CRF1 receptors. Eur J Pharmacol. 2003;548:251–6.

    Article  Google Scholar 

  • Sommer H, Harrer G. Placebo-controlled double-blind study examining the effectiveness of a hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol. 1994;7:9–11.

    Article  Google Scholar 

  • Sticher O. Plant mono-, di- and sesquiterpenoids with pharmacological or therapeutical activity. In: Wagner H, Wolff P, editors. New natural products and plant drugs with pharmacological, biological or therapeutical activity. Springer: New York; 1977.

    Google Scholar 

  • Taylor LH, Kobak KA. An open-label trial of St. John’s wort (Hypericum perforatum) in obsessive-compulsive disorder. J Clin Psychiatry. 2000;61:575–8.

    Article  CAS  PubMed  Google Scholar 

  • Thiede HM, Walper A. Inhibition of MAO and COMT by Hypericum extracts and hypericin. J Geriatr Psychiatry Neurol. 1994;7:54–6.

    Article  Google Scholar 

  • Tian J, Zhang F, Cheng J, Guo S, Liu P, Wang H. Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L. Sci Rep. 2014;4:5632.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Upton R, editor. St. John’s wort monograph. Santa Cruz: American Herbal Pharmacopoeia; 1997.

    Google Scholar 

  • Vorbach EU, Hubner WD, Arnoldt KH. Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol. 1994;1:19–23.

    Article  Google Scholar 

  • Wang D, Bai J, Sun F, Yang D. Chemical constituents and antidepressant activity of the new species Hypericum enshiense occurring in China. Phytomedicine. 2010a;17:410–3.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Shi X, Qi Z. Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels. Br J Pharmacol. 2010b;159(7):1402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weber W, Vander Stoep A, McCarty RL, Weiss NS, Biederman J, McClellan J. Hypericum perforatum (St. John’s wort) for attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 2008;299:2633–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wenzel E. On the therapy of depressive states with hypericin (preliminary results with the experimental preparation Hyp. No 1). Z Gesamte Inn Med. 1959;14:054–7.

    PubMed  CAS  Google Scholar 

  • Wheatley D. LI 160, an extract of St. John’s wort, versus amitriptyline in mildly to moderately depressed outpatients: a controlled 6-week clinical trial. Pharmacopsychiatry. 1997;30:77–80.

    Article  CAS  PubMed  Google Scholar 

  • Witte B, Harrer G, Kaptan T, Podzuweit H, Schmidt U. Treatment of depressive symptoms with a high concentration Hypericum preparation. A multicenter, placebo-controlled double-blind study. Fortschr Med. 1995;13:404–8.

    Google Scholar 

  • Wonnemann M, Singer A, Müller WE. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John’s wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology. 2000;23:188–97.

    Article  CAS  PubMed  Google Scholar 

  • Wonnemann M, Singer A, Siebert B, Müller WE. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John’s wort. Pharmacopsychiatry. 2001;34:148–51.

    Article  Google Scholar 

  • Yaşar SN, Can OD, Oztürk N, Sagratini G, Ricciutelli M, Vittori S, Maggi F. Central nervous system activities of Hypericum origanifolium extract via GABAergic and opioidergic mechanisms. Phytother Res. 2013;27:877–84.

    Article  CAS  PubMed  Google Scholar 

  • Zanoli P, Rivasi M, Baraldi C, Baraldi M. Pharmacological activity of hyperforin acetate in rats. Behav Pharmacol 2002;13:645–51.

    Article  CAS  PubMed  Google Scholar 

  • Zheleva-Dimitrova D, Nedialkov P, Momekov G. Benzophenones from Hypericum elegans with antioxidant and acetylcholinesterase inhibitory potential. Pharmacogn Mag. 2013;9:1–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Herbal Consultant, Mohali, Punjab, India

    Amritpal Singh Saroya

  2. Department of Pharmacology, Sri Guru Ram Das Institute of Medical Science, Amritsar, Punjab, India

    Jaswinder Singh

Authors
  1. Amritpal Singh Saroya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaswinder Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saroya, A.S., Singh, J. (2018). Neuropharmacology of Genus Hypericum: Hypericin and Hyperforin. In: Pharmacotherapeutic Potential of Natural Products in Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-13-0289-3_3

Download citation

Publish with us

Policies and ethics

Search

Navigation